Funded Projects › FP7
ECRIN-PPI · European clinical research infrastructures network for clinical trials and biotherapy - preparatory phase for the infrastructure
European clinical research needs an integrated and distributed infrastructure able to provide efficient support to multinational clinical trials, taking advantage of the European population and competencies, unlocking latent expertise and patients scattered across the EU member states. ECRIN (European Clinical Research Infrastructures Network) is designed to bridge the fragmentation of clinical research in Europe through the connection of national networks of clinical research centres and clinical trial units. Participants are currently Austria, Denmark, Finland, France, Germany, Hungary, Ireland, Italy, Spain, Sweden, Switzerland, the United Kingdom, and the EORTC. It will provide integrated, ‘one-stop shop’ services to investigators and sponsors in multinational studies (patient recruitment and investigation, data management, GMP manufacturing of biotherapy products, quality assurance, monitoring, ethics, regulatory affairs and adverse event reporting). With this objective, the preparation phase will consist of - WP2: selection of a legal status and of the governance structure - WP3: agreement on a financial plan leading to a long-term sustainability during the construction step and the operation phase - WP4: survey on needs in terms of GMP facilities for biopharmaceuticals and biotherapy, and their design. - WP5: education programme for multinational clinical studies - WP6: extension to other EU member states - WP7: capacity building to help national networks fulfil the sponsor’s tasks - WP8: update and upgrade of the quality assurance system - WP9: internal and external communication - WP10: accreditation of data centres - WP11: support to pilot projects Users will be investigators and sponsors in the academic and SME sector. Participants will be the national coordination of clinical research infrastructures, and national ministries and funding agencies in order to reach an agreement ensuring the long-term sustainability of the infrastructure.
Consortium · 22 organisations
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
FR · €1,379,767
MEDIZINISCHE UNIVERSITAET WIEN
AT · €468,070
REGION HOVEDSTADEN
DK · €368,900
HEINRICH-HEINE-UNIVERSITAET DUESSELDORF
DE · €686,050
AGENCIA ESPANOLA DE MEDICAMENTOS Y PRODUCTOS SANITARIOS
ES
CONSORZIO ITALIANO PER LA RICERCA IN MEDICINA (C.I.R.M.)
IT · €200,900
MMI CLINICAL RESEARCH DEVELOPMENT IRELAND
IE · €293,445
INSTITUTO DE SALUD CARLOS III
ES
ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI
IT · €399,700
EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL
BE · €156,250
ISTITUTO SUPERIORE DI SANITA
IT · €75,400
UNIVERSITAET BERN
CH · €283,210
BUNDESMINISTERIUM FUER BILDUNG UND FORSCHUNG
DE
UNIVERSITY OF LEEDS
UK · €379,440
WARSZAWSKI UNIWERSYTET MEDYCZNY
PL · €88,720
EGESZSEGUGY MINISZTERIUMI
HU · €189,140
KUOPIO INNOVATION LTD
FI · €21,764
FinnMedi Oy
FI · €114,250
Karolinska University Hospital
SE · €341,570
MEDICAL RESEARCH COUNCIL
UK
HOSPITAL CLINIC I PROVINCIAL DE BARCELONA
ES · €353,424
THE HEALTH RESEARCH BOARD
IE
Research fields
← Find collaborators and more funded projects
Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.